Published in Women's Health Weekly, September 14th, 2006
The sNDA for Mission Pharmacal is supported by data from a randomized, placebo-controlled, double-blind multicenter trial evaluating two dosing regimens of Tindamax (tinidazole). In the study, patients with BV were...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly